POTENTIATION OF RELEASE OF INTERLEUKIN-2 BY BLEOMYCIN

被引：19

作者：

HAMIED, TAA

PARKER, D

TURK, JL

机构：

来源：

IMMUNOPHARMACOLOGY | 1986年 / 12卷 / 02期

关键词：

D O I：

10.1016/0162-3109(86)90038-X

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：127 / 134

页数：8

共 18 条

[1]

EHRKE MJ, 1980, RECENT RESULTS CANC, V75, P195

[2] SELECTIVE EFFECTS OF ADRIAMYCIN ON MURINE HOST DEFENSE SYSTEMS [J].

EHRKE, MJ ;

COHEN, SA ;

MIHICH, E .

IMMUNOLOGICAL REVIEWS, 1982, 65 :55-78

[3] MACROPHAGE-DERIVED GROWTH-FACTOR FOR FIBROBLASTS AND INTERLEUKIN-1 ARE DISTINCT ENTITIES [J].

ESTES, JE ;

PLEDGER, WJ ;

GILLESPIE, GY .

JOURNAL OF LEUKOCYTE BIOLOGY, 1984, 35 (01) :115-129

[4]

GILLIS S, 1978, J IMMUNOL, V120, P2027

[5] IMMUNOMODULATORY ACTIVITY OF WY-18,251 (3-(P-CHLOROPHENYL)THIAZOLO[3,2-A]BENZIMIDAZOLE-2-ACETIC ACID) [J].

GILMAN, SC ;

CARLSON, RP ;

LEWIS, AJ .

JOURNAL OF IMMUNOPHARMACOLOGY, 1985, 7 (01) :79-98

[6] BOTH A MONOCLONAL-ANTIBODY AND ANTISERA SPECIFIC FOR DETERMINANTS UNIQUE TO INDIVIDUAL CLONED HELPER T-CELL LINES CAN SUBSTITUTE FOR ANTIGEN AND ANTIGEN-PRESENTING CELLS IN THE ACTIVATION OF T-CELLS [J].

KAYE, J ;

PORCELLI, S ;

TITE, J ;

JONES, B ;

JANEWAY, CA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1983, 158 (03) :836-856

[7]

KOVACS EJ, 1985, J LEUKOCYTE BIOL, V37, P1

[8]

KOVACS EJ, 1985, AM J PATHOL, V121, P261

[9]

MORIKAWA K, 1985, CANCER RES, V45, P1502

[10] POTENTIATION OF LYMPHOCYTE-T FUNCTION BY BLEOMYCIN [J].

PARKER, D ;

TURK, JL .

IMMUNOPHARMACOLOGY, 1984, 7 (02) :109-113

← 1 2 →